151 related articles for article (PubMed ID: 20632100)
21. The value of serum antibodies in differentiating inflammatory bowel disease, predicting disease activity and disease course in the newly diagnosed patient.
Smids C; Horjus Talabur Horje CS; Groenen MJM; van Koolwijk EHM; Wahab PJ; van Lochem EG
Scand J Gastroenterol; 2017 Oct; 52(10):1104-1112. PubMed ID: 28661185
[TBL] [Abstract][Full Text] [Related]
22. Serum anti-glycan antibody biomarkers for inflammatory bowel disease diagnosis and progression: a systematic review and meta-analysis.
Kaul A; Hutfless S; Liu L; Bayless TM; Marohn MR; Li X
Inflamm Bowel Dis; 2012 Oct; 18(10):1872-84. PubMed ID: 22294465
[TBL] [Abstract][Full Text] [Related]
23. Clinical utility of anti-glycan antibodies in pediatric Crohn's disease in comparison with an adult cohort.
Rieder F; Hahn P; Finsterhoelzl L; Schleder S; Wolf A; Dirmeier A; Lopez R; Shen B; Rogler G; Klebl F; Lang T
Inflamm Bowel Dis; 2012 Jul; 18(7):1221-31. PubMed ID: 22147427
[TBL] [Abstract][Full Text] [Related]
24. Serologic antiglycan antibodies in inflammatory bowel disease.
Lakatos PL; Papp M; Rieder F
Am J Gastroenterol; 2011 Mar; 106(3):406-12. PubMed ID: 21245832
[TBL] [Abstract][Full Text] [Related]
25. Diagnostic role and clinical association of ASCA and ANCA in Brazilian patients with inflammatory bowel disease.
Nisihara RM; de Carvalho WB; Utiyama SR; Amarante H; Baptista ML
Dig Dis Sci; 2010 Aug; 55(8):2309-15. PubMed ID: 19826949
[TBL] [Abstract][Full Text] [Related]
26. Diagnostic value of anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease.
Peeters M; Joossens S; Vermeire S; Vlietinck R; Bossuyt X; Rutgeerts P
Am J Gastroenterol; 2001 Mar; 96(3):730-4. PubMed ID: 11280542
[TBL] [Abstract][Full Text] [Related]
27. Novel anti-glycan antibodies related to inflammatory bowel disease diagnosis and phenotype.
Seow CH; Stempak JM; Xu W; Lan H; Griffiths AM; Greenberg GR; Steinhart AH; Dotan N; Silverberg MS
Am J Gastroenterol; 2009 Jun; 104(6):1426-34. PubMed ID: 19491856
[TBL] [Abstract][Full Text] [Related]
28. Anti-food and anti-microbial IgG subclass antibodies in inflammatory bowel disease.
Jansen A; Mandić AD; Bennek E; Frehn L; Verdier J; Tebrügge I; Lutz H; Streetz K; Trautwein C; Sellge G
Scand J Gastroenterol; 2016 Dec; 51(12):1453-1461. PubMed ID: 27455092
[TBL] [Abstract][Full Text] [Related]
29. Characterization of changes in serum anti-glycan antibodies in Crohn's disease--a longitudinal analysis.
Rieder F; Lopez R; Franke A; Wolf A; Schleder S; Dirmeier A; Schirbel A; Rosenstiel P; Dotan N; Schreiber S; Rogler G; Klebl F
PLoS One; 2011 May; 6(5):e18172. PubMed ID: 21573154
[TBL] [Abstract][Full Text] [Related]
30. New serological markers in inflammatory bowel disease are associated with complicated disease behaviour.
Ferrante M; Henckaerts L; Joossens M; Pierik M; Joossens S; Dotan N; Norman GL; Altstock RT; Van Steen K; Rutgeerts P; Van Assche G; Vermeire S
Gut; 2007 Oct; 56(10):1394-403. PubMed ID: 17456509
[TBL] [Abstract][Full Text] [Related]
31. Update on Anti-Saccharomyces cerevisiae antibodies, anti-nuclear associated anti-neutrophil antibodies and antibodies to exocrine pancreas detected by indirect immunofluorescence as biomarkers in chronic inflammatory bowel diseases: results of a multicenter study.
Desplat-Jégo S; Johanet C; Escande A; Goetz J; Fabien N; Olsson N; Ballot E; Sarles J; Baudon JJ; Grimaud JC; Veyrac M; Chamouard P; Humbel RL
World J Gastroenterol; 2007 Apr; 13(16):2312-8. PubMed ID: 17511029
[TBL] [Abstract][Full Text] [Related]
32. Mutations in pattern recognition receptor genes modulate seroreactivity to microbial antigens in patients with inflammatory bowel disease.
Henckaerts L; Pierik M; Joossens M; Ferrante M; Rutgeerts P; Vermeire S
Gut; 2007 Nov; 56(11):1536-42. PubMed ID: 17595233
[TBL] [Abstract][Full Text] [Related]
33. Novel anti-carbohydrate autoantibodies in patients with inflammatory bowel disease: are they useful for clinical practice?
Malickova K; Lukas M; Donoval R; Sandova P; Janatkova I
Clin Lab; 2006; 52(11-12):631-8. PubMed ID: 17175895
[TBL] [Abstract][Full Text] [Related]
34. Anti-Saccharomyces cerevisiae mannan antibodies and antineutrophil cytoplasmic autoantibodies in Greek patients with inflammatory bowel disease.
Koutroubakis IE; Petinaki E; Mouzas IA; Vlachonikolis IG; Anagnostopoulou E; Castanas E; Maniatis AN; Kouroumalis EA
Am J Gastroenterol; 2001 Feb; 96(2):449-54. PubMed ID: 11232689
[TBL] [Abstract][Full Text] [Related]
35. Association of the novel serologic anti-glycan antibodies anti-laminarin and anti-chitin with complicated Crohn's disease behavior.
Rieder F; Schleder S; Wolf A; Dirmeier A; Strauch U; Obermeier F; Lopez R; Spector L; Fire E; Yarden J; Rogler G; Dotan N; Klebl F
Inflamm Bowel Dis; 2010 Feb; 16(2):263-74. PubMed ID: 19653286
[TBL] [Abstract][Full Text] [Related]
36. Antibodies against laminaribioside and chitobioside are novel serologic markers in Crohn's disease.
Dotan I; Fishman S; Dgani Y; Schwartz M; Karban A; Lerner A; Weishauss O; Spector L; Shtevi A; Altstock RT; Dotan N; Halpern Z
Gastroenterology; 2006 Aug; 131(2):366-78. PubMed ID: 16890590
[TBL] [Abstract][Full Text] [Related]
37. ASCA, ANCA, ALCA and Many More: Are They Useful in the Diagnosis of Inflammatory Bowel Disease?
Zhou G; Song Y; Yang W; Guo Y; Fang L; Chen Y; Liu Z
Dig Dis; 2016; 34(1-2):90-7. PubMed ID: 26982193
[TBL] [Abstract][Full Text] [Related]
38. Serologic testing with ANCA, ASCA, and anti-OmpC in children and young adults with Crohn's disease and ulcerative colitis: diagnostic value and correlation with disease phenotype.
Zholudev A; Zurakowski D; Young W; Leichtner A; Bousvaros A
Am J Gastroenterol; 2004 Nov; 99(11):2235-41. PubMed ID: 15555007
[TBL] [Abstract][Full Text] [Related]
39. Antilaminaribioside and antichitobioside antibodies in inflammatory bowel disease.
Rejchrt S; Drahosová M; Kopácová M; Cyrany J; Douda T; Pintér M; Bures J
Folia Microbiol (Praha); 2008; 53(4):373-6. PubMed ID: 18759124
[TBL] [Abstract][Full Text] [Related]
40. Increased levels of anti-glycan antibodies in patients with cystic fibrosis.
Hirche TO; Stein J; Hirche H; Hausmann J; Wagner TO; Behrens F; Schröder O
Eur J Med Res; 2011 Sep; 16(9):385-90. PubMed ID: 22024437
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
